FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2923980510> ?p ?o ?g. }

• W2923980510 endingPage "1339" @default.
• W2923980510 startingPage "1328" @default.
• W2923980510 abstract "Ruxolitinib is a JAK 1/2 inhibitor approved in 2011 by the Food and Drug Administration (FDA) for the treatment of patients with myelofibrosis. Currently, side effects related to the use of ruxolitinib are routinely managed through therapeutic dose adjustment and blood count monitoring. However, the evaluation of plasma concentration of this compound and other tyrosine kinase inhibitors is becoming of increasing importance, since the therapeutic efficacy of this class of drugs is characterized by a marked variability caused by the presence of genetic polymorphisms, drug–drug interactions, and potential poor patient adherence. Therapeutic drug monitoring of these compounds is thus required to ensure both an optimal response and the reduction of potential adverse effects. In this manuscript, we describe the development and validation of a reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of ruxolitinib in plasma, using a liquid chromatographic system equipped with a fluorometric detector (FL) and a mobile phase at pH 4.8 composed of 67:33 water:acetonitrile. The excitation and emission wavelengths were set to 320 nm and 386 nm, respectively. The lower limit of quantification in plasma was 0.1 ng/mL, and the response was linear across the concentration range from 0.2 to 500 ng/mL. The developed methodology, based on a simple extraction procedure and on a rapid chromatographic analysis involving a 5 minutes total analysis time, was validated according to the European Medicines Agency (EMA) guidelines, and may be considered as alternative and complementary to other previously proposed approaches." @default.
• W2923980510 created "2019-04-01" @default.
• W2923980510 creator A5006293193 @default.
• W2923980510 creator A5026122857 @default.
• W2923980510 creator A5032805948 @default.
• W2923980510 creator A5037698212 @default.
• W2923980510 creator A5063962228 @default.
• W2923980510 creator A5067556927 @default.
• W2923980510 creator A5072623447 @default.
• W2923980510 creator A5076935187 @default.
• W2923980510 creator A5085836855 @default.
• W2923980510 creator A5087994776 @default.
• W2923980510 date "2019-03-26" @default.
• W2923980510 modified "2023-10-16" @default.
• W2923980510 title "Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples" @default.
• W2923980510 cites W1968224278 @default.
• W2923980510 cites W2018254868 @default.
• W2923980510 cites W2021908772 @default.
• W2923980510 cites W2023680965 @default.
• W2923980510 cites W2043021219 @default.
• W2923980510 cites W2046963455 @default.
• W2923980510 cites W2059200513 @default.
• W2923980510 cites W2091528107 @default.
• W2923980510 cites W2110369495 @default.
• W2923980510 cites W2116650111 @default.
• W2923980510 cites W2121743767 @default.
• W2923980510 cites W2148691415 @default.
• W2923980510 cites W2154558042 @default.
• W2923980510 cites W2164716517 @default.
• W2923980510 cites W2310252693 @default.
• W2923980510 cites W2321718103 @default.
• W2923980510 cites W2469022727 @default.
• W2923980510 cites W2592070663 @default.
• W2923980510 cites W2799884779 @default.
• W2923980510 cites W3175858017 @default.
• W2923980510 cites W4241096387 @default.
• W2923980510 cites W4244757272 @default.
• W2923980510 doi "https://doi.org/10.1080/00032719.2018.1537283" @default.
• W2923980510 hasPublicationYear "2019" @default.
• W2923980510 type Work @default.
• W2923980510 sameAs 2923980510 @default.
• W2923980510 citedByCount "10" @default.
• W2923980510 countsByYear W29239805102020 @default.
• W2923980510 countsByYear W29239805102021 @default.
• W2923980510 countsByYear W29239805102022 @default.
• W2923980510 countsByYear W29239805102023 @default.
• W2923980510 crossrefType "journal-article" @default.
• W2923980510 hasAuthorship W2923980510A5006293193 @default.
• W2923980510 hasAuthorship W2923980510A5026122857 @default.
• W2923980510 hasAuthorship W2923980510A5032805948 @default.
• W2923980510 hasAuthorship W2923980510A5037698212 @default.
• W2923980510 hasAuthorship W2923980510A5063962228 @default.
• W2923980510 hasAuthorship W2923980510A5067556927 @default.
• W2923980510 hasAuthorship W2923980510A5072623447 @default.
• W2923980510 hasAuthorship W2923980510A5076935187 @default.
• W2923980510 hasAuthorship W2923980510A5085836855 @default.
• W2923980510 hasAuthorship W2923980510A5087994776 @default.
• W2923980510 hasConcept C10390740 @default.
• W2923980510 hasConcept C119128265 @default.
• W2923980510 hasConcept C126322002 @default.
• W2923980510 hasConcept C179998833 @default.
• W2923980510 hasConcept C185592680 @default.
• W2923980510 hasConcept C2776112149 @default.
• W2923980510 hasConcept C2780007613 @default.
• W2923980510 hasConcept C2780035454 @default.
• W2923980510 hasConcept C2780076729 @default.
• W2923980510 hasConcept C2780272996 @default.
• W2923980510 hasConcept C43617362 @default.
• W2923980510 hasConcept C71924100 @default.
• W2923980510 hasConcept C95986675 @default.
• W2923980510 hasConcept C98274493 @default.
• W2923980510 hasConceptScore W2923980510C10390740 @default.
• W2923980510 hasConceptScore W2923980510C119128265 @default.
• W2923980510 hasConceptScore W2923980510C126322002 @default.
• W2923980510 hasConceptScore W2923980510C179998833 @default.
• W2923980510 hasConceptScore W2923980510C185592680 @default.
• W2923980510 hasConceptScore W2923980510C2776112149 @default.
• W2923980510 hasConceptScore W2923980510C2780007613 @default.
• W2923980510 hasConceptScore W2923980510C2780035454 @default.
• W2923980510 hasConceptScore W2923980510C2780076729 @default.
• W2923980510 hasConceptScore W2923980510C2780272996 @default.
• W2923980510 hasConceptScore W2923980510C43617362 @default.
• W2923980510 hasConceptScore W2923980510C71924100 @default.
• W2923980510 hasConceptScore W2923980510C95986675 @default.
• W2923980510 hasConceptScore W2923980510C98274493 @default.
• W2923980510 hasIssue "8" @default.
• W2923980510 hasLocation W29239805101 @default.
• W2923980510 hasOpenAccess W2923980510 @default.
• W2923980510 hasPrimaryLocation W29239805101 @default.
• W2923980510 hasRelatedWork W1964888264 @default.
• W2923980510 hasRelatedWork W1973892552 @default.
• W2923980510 hasRelatedWork W1987255080 @default.
• W2923980510 hasRelatedWork W2053496326 @default.
• W2923980510 hasRelatedWork W2063706329 @default.
• W2923980510 hasRelatedWork W2084062459 @default.
• W2923980510 hasRelatedWork W2096641431 @default.
• W2923980510 hasRelatedWork W2137297405 @default.
• W2923980510 hasRelatedWork W2141316828 @default.

• next